# Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients

> **NCT00406978** · PHASE1,PHASE2 · COMPLETED · sponsor: **Silvio Aime** · enrollment: 24 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Melphalan
- **DRUG:** Thalidomide
- **DRUG:** Defibrotide

## Key facts

- **NCT ID:** NCT00406978
- **Lead sponsor:** Silvio Aime
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2010-09
- **Final completion:** 2014-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406978, "Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00406978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*